Healthy high growth potential
Ergebnisse
4
2 neu
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 Unternehmen
| Unternehmen | Letzter Preis | 7D Rückkehr | 1J Rückkehr | Marktkapitalisierung | Analysten Ziel | Bewertung | Wachstum | Div. Rendite | Industrie | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
DONKEY Neu | DKK 8.40 | -5.1% | 21.7% | DKK 340.3m | DKK 9.50 | 170.7 | 99.5% | n/a | Transportation | ||
GUBRA Neu | DKK 400.00 | 1.3% | 2.6% | DKK 6.6b | DKK 501.00 | 24.2 | 108.4% | 0% | Pharmaceuticals & Biotech | ||
BIOPOR | DKK 1.21 | 0% | -5.5% | DKK 599.1m | DKK 1.75 | 15.6 | 66.2% | n/a | Pharmaceuticals & Biotech | ||
CBRAIN | DKK 77.50 | 41.2% | -58.4% | DKK 1.5b | DKK 90.00 | 32.4 | 27.1% | 1.3% | Software |
Page 1 of 1
